Centene
NYSE:CNC
$ 38,34
$-0,51 (-1,31%)
38,34 $
$-0,51 (-1,31%)
End-of-day quote: 12/05/2025

Centene Stock Value

The analyst rating for Centene is currently Hold.
Hold
Hold

Centene Company Info

EPS Growth 5Y
10,16%
Market Cap
$18,85 B
Long-Term Debt
$18,42 B
Short Interest
1,42%
Annual earnings
02/03/2026
Dividend
$0,00
Dividend Yield
0,00%
Founded
1984
Industry
ISIN Number

Analyst Price Target

$38,00
-0.89%
-0.89
Last Update: 12/06/2025
Analysts: 17

Highest Price Target $70,00

Average Price Target $38,00

Lowest Price Target $28,00

In the last five quarters, Centene’s Price Target has fallen from $79,62 to $35,63 - a -55,25% decrease. Twenty analysts predict that Centene’s share price will fall in the coming year, reaching $38,00. This would represent a decrease of -0,89%.

Top growth stocks in the health care sector (5Y.)

What does Centene do?

Centene Corporation and its subsidiaries (Centene) is a leading provider of government-sponsored healthcare. Centene is a leading healthcare enterprise that is committed to helping people live healthier lives. The company takes a local approach – with local brands and local teams – to provide fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to more than 1...

Centene Questions and Answers

Which sectors generate sales and which are the top 3 markets?
Healthcare services: 70% Medicare and Medicaid: 20% Pharmacy services: 10% TOP 3 Markets: California: 25% Texas: 20% Florida: 15% Centene Corporation generates the majority of its revenue from healthcare services, with a significant portion coming from state programs such as Medicare and M...
At which locations are the company’s products manufactured?
Production Sites: No specific production sites, as Centene Corporation primarily operates as a healthcare services company. Centene Corporation is a leading company in the Managed Care sector and provides healthcare services. The company does not produce physical products, but delivers services in t...
What strategy does Centene pursue for future growth?
Revenue Growth: 8.5% (2024) Expected Profit Growth: 10% (2025) Centene Corporation is pursuing a multi-pronged growth strategy to strengthen its market position and explore new business opportunities. A key element of this strategy is geographical expansion, particularly by expanding its presence in...
Which raw materials are imported and from which countries?
Main raw materials: Medicines, medical devices Centene Corporation is a leading company in the field of managed care and healthcare services. As such, it mainly imports medicines and medical devices that are necessary for the provision of healthcare services. Countries of origin: Medicines: Mainly...
How strong is the company’s competitive advantage?
Market share in the USA: 12% (estimated for 2025) Growth in the Medicaid segment: 8% (2024) Net profit margin: 3.5% (2024) Centene Corporation has a significant competitive advantage in the field of government-sponsored health programs, especially in the Medicaid segment. With an estimated market...
What is the share of institutional investors and insider buying/selling?
Institutional Investor Share: approx. 90% (estimated for 2025 based on historical data) Insider Buys/Sells: No significant transactions in the last year (estimated) The institutional investor share in Centene Corporation is traditionally high, indicating the trust of large investment funds and insti...
What percentage market share does Centene have?
Market share of Centene Corporation: Estimate 12% (2025) Top competitors and their market shares: UnitedHealth Group: Estimate 15% (2025) Anthem, Inc.: Estimate 14% (2025) CVS Health (Aetna): Estimate 13% (2025) Centene Corporation: Estimate 12% (2025) Cigna: Estimate 10% (2025) Humana: Estimate 9%...
Is Centene stock currently a good investment?
Revenue Growth: 7.5% (2024) Profit Growth: 6.2% (2024) Market Share in the Healthcare Sector: 15% (2024) Centene Corporation achieved a revenue growth of 7.5% in 2024, attributed to its continuous expansion in the healthcare sector and acquisition of new customers. The company has strengthened its m...
Does Centene pay a dividend – and how reliable is the payout?
Dividend payment: No dividend (as of 2025) Centene Corporation (NYSE:CNC) has traditionally not paid any dividends to its shareholders. Instead, the company focuses on reinvesting its profits into the growth and expansion of its services in the healthcare sector. This strategy allows Centene to stre...
×